stockrow
Friday 6 November 2026
Export ZOMDF’s income statement to Excel — free account
Zomedica Corp.
ZOMDF Healthcare Medical Devices
Zomedica Corp.’s revenue for fiscal 2025 (year ended December 2025) was $32.0 million, up 17.4% from fiscal 2024.
- Revenue
- +22.3%
- EPS
- +48.4%
- Free cash flow
- +32.5%
Quarter to September 2026, against a year earlier
0.09
0.00
0.00%
Follow ZOMDF
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 From the 10-Q filed 4 Nov | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
4 | 5 | 5 | 5 |
| (52.63%) | (18.56%) | (16.29%) | (14.28%) | ||
| (48.96%) | (17.07%) | (14.88%) | (13.01%) | ||
ROIC |
(84.84%) | (24.34%) | (20.54%) | (17.12%) | |
Return on Tangible Assets |
(108.41%) | (31.40%) | (27.49%) | (24.27%) | |
Average Days of Receivables |
39.37 | 51.05 | 59.63 | 67.72 | |
Free Cash Flow per Share |
(0.02) | (0.02) | (0.02) | (0.01) | |
Free Cash Flow |
(18.59) | (17.32) | (15.03) | (13.46) | |
Capital Expenditures |
(0.95) | (1.06) | (1.66) | (1.99) | |
| Other line items | |||||
Cash ROIC |
(11.03%) | (10.93%) | (9.92%) | (9.32%) | |
Accounts Receivable Turnover |
9.82 | 9.91 | 8.25 | 7.16 | |
Accounts Payable Turnover |
5.68 | 5.15 | 7.00 | 7.45 | |
Inventory Turnover |
1.95 | 2.06 | 2.17 | 2.47 | |
Average Days of Payables |
60.58 | 69.39 | 44.96 | 54.93 | |
Days of Inventory on Hand |
195.53 | 185.29 | 173.25 | 151.14 | |
Tax Rate |
0.00 | (0.01) | (0.01) | (0.01) | |
Research and Development Expense of Revenue |
22.37% | 18.84% | 15.32% | 13.11% | |
Selling, General and Administrative Expense of Revenue |
134.35% | 119.42% | 106.39% | 96.27% | |
Share Based Compensation of Revenue |
7.72% | 7.27% | 6.25% | 3.62% | |
Operating CF/Net income |
0.22 | 0.72 | 0.71 | 0.72 | |
Depreciation/Fixed assets |
0.35 | 0.35 | 0.36 | 0.00 | |
Capex/Depreciation |
(0.13) | (0.15) | (0.23) | 0.00 | |
Revenue per Share |
0.03 | 0.04 | 0.04 | 0.04 | |
Operating CF per Share |
(0.02) | (0.02) | (0.01) | (0.01) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.03 | 0.03 | 0.05 | 0.05 |
Columns are period end dates · fundamentals updated 4 Nov 2026